Cigna Corporation (CI)
USD 327.75
(-0.51%)
USD 327.75
(-0.51%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 8.53 Billion USD | -45.66% |
| 2022 | 9.5 Billion USD | 13.78% |
| 2021 | 8.35 Billion USD | -4.15% |
| 2020 | 8.71 Billion USD | 109.03% |
| 2019 | -96.54 Billion USD | -2472.11% |
| 2018 | 4.07 Billion USD | -5.66% |
| 2017 | 4.31 Billion USD | 43.66% |
| 2016 | 3 Billion USD | -10.2% |
| 2015 | 3.34 Billion USD | 0.97% |
| 2014 | 3.31 Billion USD | 52.21% |
| 2013 | 2.17 Billion USD | -12.12% |
| 2012 | 2.47 Billion USD | 14.15% |
| 2011 | 2.16 Billion USD | 5.91% |
| 2010 | 2.04 Billion USD | 8.02% |
| 2009 | 1.89 Billion USD | 396.34% |
| 2008 | 382 Million USD | -76.51% |
| 2007 | 1.62 Billion USD | -6.07% |
| 2006 | 1.73 Billion USD | -3.46% |
| 2005 | 1.79 Billion USD | -19.81% |
| 2004 | 2.23 Billion USD | 147.62% |
| 2003 | 903 Million USD | 258.42% |
| 2002 | -570 Million USD | -138.08% |
| 2001 | 1.49 Billion USD | 0.0% |
| 2000 | 1.49 Billion USD | -34.74% |
| 1999 | 2.29 Billion USD | 14.13% |
| 1998 | 2.01 Billion USD | 21.82% |
| 1997 | 1.65 Billion USD | 3.06% |
| 1996 | 1.6 Billion USD | 537.85% |
| 1995 | 251 Million USD | -68.82% |
| 1994 | 805 Million USD | 387.88% |
| 1993 | 165 Million USD | 7.84% |
| 1992 | 153 Million USD | -73.62% |
| 1991 | 580 Million USD | 59.34% |
| 1990 | 364 Million USD | -47.7% |
| 1989 | 696 Million USD | 22.08% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 2.25 Billion USD | 119.24% |
| 2024 Q2 | 2.41 Billion USD | 6.91% |
| 2024 Q3 | 2.57 Billion USD | -28.19% |
| 2023 Q2 | 2.22 Billion USD | 75.43% |
| 2023 Q3 | 2.24 Billion USD | 0.86% |
| 2023 Q1 | 1.26 Billion USD | -22.0% |
| 2023 FY | 5.16 Billion USD | -45.66% |
| 2023 Q4 | 1.02 Billion USD | -54.06% |
| 2022 FY | 9.5 Billion USD | 13.78% |
| 2022 Q1 | 1.83 Billion USD | 15.43% |
| 2022 Q2 | 2.27 Billion USD | 24.0% |
| 2022 Q3 | 3.77 Billion USD | 66.04% |
| 2022 Q4 | 1.62 Billion USD | -57.0% |
| 2021 Q1 | 1.95 Billion USD | -76.0% |
| 2021 Q2 | 2.14 Billion USD | 9.71% |
| 2021 Q4 | 1.58 Billion USD | -30.78% |
| 2021 Q3 | 2.29 Billion USD | 6.85% |
| 2021 FY | 8.35 Billion USD | -4.15% |
| 2020 Q4 | 8.15 Billion USD | 286.76% |
| 2020 Q2 | 2.63 Billion USD | 28.04% |
| 2020 Q1 | 2.06 Billion USD | -74.48% |
| 2020 FY | 8.71 Billion USD | 109.03% |
| 2020 Q3 | 2.1 Billion USD | -20.12% |
| 2019 FY | -96.54 Billion USD | -2472.11% |
| 2019 Q4 | 8.07 Billion USD | 280.45% |
| 2019 Q1 | 2.23 Billion USD | 891.11% |
| 2019 Q3 | 2.12 Billion USD | -1.85% |
| 2019 Q2 | 2.16 Billion USD | -3.0% |
| 2018 Q4 | 225 Million USD | -78.18% |
| 2018 FY | 4.07 Billion USD | -5.66% |
| 2018 Q3 | 1.03 Billion USD | -6.27% |
| 2018 Q2 | 1.1 Billion USD | -9.54% |
| 2018 Q1 | 1.21 Billion USD | 60.63% |
| 2017 Q2 | 1.13 Billion USD | 27.04% |
| 2017 Q4 | 757 Million USD | -8.13% |
| 2017 Q3 | 824 Million USD | -27.53% |
| 2017 FY | 4.31 Billion USD | 43.66% |
| 2017 Q1 | 895 Million USD | 46.0% |
| 2016 Q3 | 746 Million USD | -9.02% |
| 2016 Q1 | 824 Million USD | 23.54% |
| 2016 FY | 3 Billion USD | -10.2% |
| 2016 Q2 | 820 Million USD | -0.49% |
| 2016 Q4 | 613 Million USD | -17.83% |
| 2015 FY | 3.34 Billion USD | 0.97% |
| 2015 Q1 | 856 Million USD | 16.15% |
| 2015 Q2 | 940 Million USD | 9.81% |
| 2015 Q3 | 881 Million USD | -6.28% |
| 2015 Q4 | 667 Million USD | -24.29% |
| 2014 FY | 3.31 Billion USD | 52.21% |
| 2014 Q4 | 737 Million USD | -10.23% |
| 2014 Q2 | 902 Million USD | 5.87% |
| 2014 Q1 | 852 Million USD | 58.96% |
| 2014 Q3 | 821 Million USD | -8.98% |
| 2013 Q2 | 766 Million USD | 963.89% |
| 2013 FY | 2.17 Billion USD | -12.12% |
| 2013 Q4 | 536 Million USD | -32.92% |
| 2013 Q3 | 799 Million USD | 4.31% |
| 2013 Q1 | 72 Million USD | -88.35% |
| 2012 Q2 | 655 Million USD | 5.99% |
| 2012 Q1 | 618 Million USD | 19.77% |
| 2012 FY | 2.47 Billion USD | 14.15% |
| 2012 Q4 | 618 Million USD | -21.37% |
| 2012 Q3 | 786 Million USD | 20.0% |
| 2011 FY | 2.16 Billion USD | 5.91% |
| 2011 Q3 | 346 Million USD | -51.13% |
| 2011 Q1 | 599 Million USD | 10.11% |
| 2011 Q2 | 708 Million USD | 18.2% |
| 2011 Q4 | 516 Million USD | 49.13% |
| 2010 Q3 | 510 Million USD | 16.44% |
| 2010 Q2 | 438 Million USD | 4.04% |
| 2010 Q1 | 421 Million USD | -16.96% |
| 2010 FY | 2.04 Billion USD | 8.02% |
| 2010 Q4 | 544 Million USD | 6.67% |
| 2009 Q1 | 273 Million USD | 180.53% |
| 2009 Q2 | 630 Million USD | 130.77% |
| 2009 Q3 | 487 Million USD | -22.7% |
| 2009 Q4 | 507 Million USD | 4.11% |
| 2009 FY | 1.89 Billion USD | 396.34% |
| 2008 Q4 | -339 Million USD | -246.12% |
| 2008 Q2 | 412 Million USD | 442.11% |
| 2008 Q1 | 76 Million USD | -80.41% |
| 2008 FY | 382 Million USD | -76.51% |
| 2008 Q3 | 232 Million USD | -43.69% |
| 2007 FY | 1.62 Billion USD | -6.07% |
| 2007 Q4 | 388 Million USD | -23.02% |
| 2007 Q3 | 504 Million USD | 53.66% |
| 2007 Q2 | 328 Million USD | -22.82% |
| 2007 Q1 | 425 Million USD | 21.78% |
| 2006 Q1 | 528 Million USD | 71.43% |
| 2006 FY | 1.73 Billion USD | -3.46% |
| 2006 Q4 | 349 Million USD | -21.04% |
| 2006 Q3 | 442 Million USD | 8.33% |
| 2006 Q2 | 408 Million USD | -22.73% |
| 2005 Q3 | 383 Million USD | -12.36% |
| 2005 Q1 | 665 Million USD | -12.27% |
| 2005 Q2 | 437 Million USD | -34.29% |
| 2005 FY | 1.79 Billion USD | -19.81% |
| 2005 Q4 | 308 Million USD | -19.58% |
| 2004 Q3 | 514 Million USD | -33.76% |
| 2004 FY | 2.23 Billion USD | 147.62% |
| 2004 Q1 | 327 Million USD | -21.58% |
| 2004 Q4 | 758 Million USD | 47.47% |
| 2004 Q2 | 776 Million USD | 137.31% |
| 2003 Q1 | 330 Million USD | 468.97% |
| 2003 Q4 | 417 Million USD | 48.4% |
| 2003 Q3 | 281 Million USD | 464.94% |
| 2003 FY | 903 Million USD | 258.42% |
| 2003 Q2 | -77 Million USD | -123.33% |
| 2002 FY | -570 Million USD | -138.08% |
| 2002 Q1 | 331 Million USD | 17.79% |
| 2002 Q2 | 325 Million USD | -1.81% |
| 2002 Q3 | -1.28 Billion USD | -495.08% |
| 2002 Q4 | 58 Million USD | 104.52% |
| 2001 Q4 | 281 Million USD | -31.63% |
| 2001 FY | 1.49 Billion USD | 0.0% |
| 2001 Q1 | 420 Million USD | 4.74% |
| 2001 Q3 | 411 Million USD | 6.75% |
| 2001 Q2 | 385 Million USD | -8.33% |
| 2000 Q4 | 401 Million USD | -6.74% |
| 2000 Q1 | 420 Million USD | -5.62% |
| 2000 FY | 1.49 Billion USD | -34.74% |
| 2000 Q2 | 246 Million USD | -41.43% |
| 2000 Q3 | 430 Million USD | 74.8% |
| 1999 Q1 | 339 Million USD | -10.55% |
| 1999 Q4 | 445 Million USD | -60.65% |
| 1999 Q3 | 1.13 Billion USD | 184.17% |
| 1999 Q2 | 398 Million USD | 17.4% |
| 1999 FY | 2.29 Billion USD | 14.13% |
| 1998 FY | 2.01 Billion USD | 21.82% |
| 1998 Q3 | 392 Million USD | -16.77% |
| 1998 Q4 | 379 Million USD | -3.32% |
| 1998 Q2 | 471 Million USD | -38.67% |
| 1998 Q1 | 768 Million USD | 104.8% |
| 1997 Q4 | 375 Million USD | -12.18% |
| 1997 Q2 | 411 Million USD | -5.95% |
| 1997 Q1 | 437 Million USD | -5.82% |
| 1997 FY | 1.65 Billion USD | 3.06% |
| 1997 Q3 | 427 Million USD | 3.89% |
| 1996 Q4 | 464 Million USD | 6.91% |
| 1996 Q2 | 345 Million USD | -3.63% |
| 1996 FY | 1.6 Billion USD | 537.85% |
| 1996 Q1 | 358 Million USD | -16.36% |
| 1996 Q3 | 434 Million USD | 25.8% |
| 1995 Q1 | 402 Million USD | 58.89% |
| 1995 Q4 | 428 Million USD | 148.47% |
| 1995 Q3 | -883 Million USD | -390.46% |
| 1995 FY | 251 Million USD | -68.82% |
| 1995 Q2 | 304 Million USD | -24.38% |
| 1994 FY | 805 Million USD | 387.88% |
| 1994 Q4 | 253 Million USD | 42.13% |
| 1994 Q3 | 178 Million USD | -12.75% |
| 1994 Q2 | 204 Million USD | 20.0% |
| 1994 Q1 | 170 Million USD | -35.61% |
| 1993 Q2 | 122 Million USD | 205.0% |
| 1993 Q1 | 40 Million USD | 385.71% |
| 1993 FY | 165 Million USD | 7.84% |
| 1993 Q3 | -261 Million USD | -313.93% |
| 1993 Q4 | 264 Million USD | 201.15% |
| 1992 FY | 153 Million USD | -73.62% |
| 1992 Q2 | 161 Million USD | 9.52% |
| 1992 Q4 | -14 Million USD | 90.07% |
| 1992 Q3 | -141 Million USD | -187.58% |
| 1992 Q1 | 147 Million USD | 2.8% |
| 1991 Q1 | 48 Million USD | -61.29% |
| 1991 Q3 | 146 Million USD | -39.92% |
| 1991 Q4 | 143 Million USD | -2.05% |
| 1991 Q2 | 243 Million USD | 406.25% |
| 1991 FY | 580 Million USD | 59.34% |
| 1990 Q1 | 50 Million USD | -80.54% |
| 1990 Q4 | 124 Million USD | 663.64% |
| 1990 Q3 | -22 Million USD | -110.38% |
| 1990 Q2 | 212 Million USD | 324.0% |
| 1990 FY | 364 Million USD | -47.7% |
| 1989 Q1 | 85.5 Million USD | -39.75% |
| 1989 Q4 | 256.9 Million USD | 81.68% |
| 1989 Q2 | 144 Million USD | 68.42% |
| 1989 Q3 | 141.4 Million USD | -1.81% |
| 1989 FY | 696 Million USD | 22.08% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Centene Corporation | 2.93 Billion USD | -191.331% |
| CVS Health Corporation | 13.74 Billion USD | 37.888% |
| Elevance Health Inc. | 133.96 Billion USD | 93.628% |
| Humana Inc. | 4.01 Billion USD | -112.709% |
| Molina Healthcare, Inc. | 1.57 Billion USD | -442.657% |
| Oscar Health, Inc. | -235.61 Million USD | 3722.859% |
| UnitedHealth Group Incorporated | 32.35 Billion USD | 73.62% |